Clinical Trials Browser

Hereditary pancreatitis, Breast Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Dysplastic Nevus Syndrome, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Peutz-Jeghers Syndrome

NCT07079228 2025-09-23

A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer

Phase 3 Recruiting

602 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07155525 2025-09-18

NBCA-MS

Phase 3 Recruiting

194 enrolled

Gastrointestinal

Bile Duct Neoplasms, Duodenal Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma

NCT07081360 2025-08-29

Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer

Phase 3 Recruiting

262 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07066098 2025-08-15

A Multicenter Study of IBI343 Monotherapy Versus Placebo in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, Pancreatic Cancer(G-HOPE-002)

Phase 3 Recruiting

201 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06897644 2025-05-25

PANThEON

Phase 3 Recruiting

340 enrolled

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT06332274 2025-05-13

UMBRELLA

Phase 3 Recruiting

717 enrolled

GastrointestinalSarcomaThoracic

Colonic Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Sarcoma

NCT06427447 2025-02-04

ADJUPANC

Phase 3 Recruiting

770 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06714604 2024-12-03

ADVANTAGE

Phase 3 Recruiting

432 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT05744219 2024-10-21

IRIS

Phase 3 Recruiting

338 enrolled

Gastrointestinal

Aortic Aneurysm, Liver Neoplasms, Pancreatic Neoplasms

NCT06391892 2024-04-30

LIQUIPANC

Phase 3 Recruiting

100 enrolled

Gastrointestinal

Neoplastic Cells, Circulating, Pancreatic Neoplasms

NCT06017284 2023-11-24

PTCA199-5

Phase 3 Recruiting

100 enrolled

Gastrointestinal

Nausea, Pancreatic Neoplasms, Vomiting

NCT04969731 2021-11-22

Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer

Phase 3 Recruiting

408 enrolled

Gastrointestinal

Pancreatic Neoplasms

Clinical Trials

DAWN-303

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

MAPKeeper 301

RASolute 303

LAP100

RASolute 304

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer

Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?

CATIQ P3

CAPS5

A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer

NBCA-MS

Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer

A Multicenter Study of IBI343 Monotherapy Versus Placebo in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, Pancreatic Cancer(G-HOPE-002)

PANThEON

UMBRELLA

ADJUPANC

ADVANTAGE

IRIS

LIQUIPANC

PTCA199-5

Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer